Cross Linking for Treatment of Corneal Infection

NATerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Infectious Keratitis
Interventions
DRUG

riboflavin

riboflavin 0.1% is applied every 2 minutes for 30 minutes

DEVICE

UVX Light

UVX 365 nm wavelength light source is applied with continued application of riboflavin 0.1%

Trial Locations (1)

46260

Price Vision Group, Indianapolis

Sponsors
All Listed Sponsors
collaborator

Cornea Research Foundation of America

OTHER

lead

Price Vision Group

INDUSTRY